In a preferred embodiment, the composition comprises a drug capable of modulating the specific binding of the GPCR with a ligand on a target cell. [0233] Antibodies [0234] Also, antibodies including both polyclonal and monoclonal antibodies, and drugs that modulate the production or activity of the modified GPCRs and/or their biologically active fragments or subunits may possess certain diagnostic